Global point prevalence survey of antimicrobial consumption in Brazilian hospitals

Carregando...
Imagem de Miniatura
Citações na Scopus
20
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
W B SAUNDERS CO LTD
Autores
GOOSSENS, H.
VERSPORTEN, A.
MACHADO, Anna
COCENTINO, Brunno
DONINI, Camila
CARRILHO, Claudia
TAKEDA, Christianne
RODRIGUES, Cristhieni
Citação
JOURNAL OF HOSPITAL INFECTION, v.104, n.2, p.165-171, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: The inappropriate use of antimicrobials and increased rates of antimicrobial resistance is a challenge all over the world. Although antibiotic stewardship is recommended by the Brazilian government, data regarding antibiotic use in Brazilian hospitals are scarce. The aim of this study was to conduct a point prevalence survey of antimicrobial use in 18 Brazilian hospitals. Methods: Eighteen Brazilian hospitals conducted the Global Point Prevalence Survey of Antimicrobial Consumption and Resistance (Global-PPS) in 2017. The study enrolled inpatients on antimicrobials. Data collection included details on the antimicrobial prescriptions. A web-based programme was used for data-entry, validation and reporting. The Global-PPS was developed by the University of Antwerp and bioMerieux provided funding support. Findings: A total of 1801 patients were evaluated, of which 941 (52.2%) were on antimicrobials. Four hundred (42.5%) patients were given at least two antimicrobials. Out of the 1317 antibacterials for systemic use, 514 (39%) were prescribed for community-acquired infections, 533 (40.5%) for healthcare-associated infections and 248 (18.8%) for prophylactic use. The most frequently used antimicrobials were ceftriaxone (12.8%), meropenem (12.3%) and vancomycin (10.3%). Pneumonia or lower respiratory tract infection was the most common site of infection (29.2%). In general, antimicrobials were given mainly parenterally (91%) and empirically (81.2%). Conclusions: A high prevalence of antibiotic use was observed in the 18 Brazilian hospitals. The antibiotics were prescribed mainly empirically. Intravenous broad-spectrum antibiotics were the most frequent antimicrobials used, showing that reinforcement of de-escalation strategy is needed. The Global-PPS data can be very useful for monitoring stewardship programmes and intervention.
Palavras-chave
Stewardship, Point prevalence, Antibiotic consumption, Point prevalence survey, Brazil
Referências
  1. [Anonymous], 2018, ATL GEOGR ESC IBGE, P224
  2. [Anonymous], AN THER CHEM ATC CLA
  3. Ansari F, 2009, CLIN INFECT DIS, V49, P1496, DOI 10.1086/644617
  4. Black E, 2018, CAN J HOSP PHARM, V71, P234
  5. BRASIL. ANVISA, 2017, CRIT DIAGN INF REL A
  6. BRASIL. ANVISA, 2017, B SEG PAC QUAL SERV
  7. Cai YY, 2017, CLIN INFECT DIS, V64, pS61, DOI 10.1093/cid/cix103
  8. CDC, 2017, ANT US US 2017 PROGR
  9. Cosgrove SE, 2006, CLIN INFECT DIS, V42, pS82, DOI 10.1086/499406
  10. Cotta MO, 2016, INTERN MED J, V46, P1182, DOI 10.1111/imj.13209
  11. European Centre for Disease Prevention and Control (ECDC) Stockholm, 2013, POINT PREV SURV HEAL
  12. Giaccone P, 2013, J PREV MED HYG, V54, P200
  13. Jones RN, 2013, BRAZ J INFECT DIS, V17, P672, DOI 10.1016/j.bjid.2013.07.002
  14. Karlowsky JA, 2017, BRAZ J INFECT DIS, V21, P343, DOI 10.1016/j.bjid.2017.03.006
  15. Lee C, 2015, J EPIDEMIOL GLOB HEA, V5, P143, DOI 10.1016/j.jegh.2014.06.003
  16. Moura ML, 2015, MED US, V94, P1
  17. Paterson DL, 2006, CLIN INFECT DIS, V42, pS90, DOI 10.1086/499407
  18. Robert J, 2012, J ANTIMICROB CHEMOTH, V67, P1020, DOI 10.1093/jac/dkr571
  19. Rodrigues FD, 2010, CIENC SAUDE COLETIVA, V15, P1239, DOI 10.1590/S1413-81232010000700033
  20. Versporten A, 2018, LANCET GLOB HEALTH, V6, pE619, DOI [10.1016/S2214-109X(18)30186-4, 10.1016/s2214-109x(18)30186-4]
  21. Willemsen I, 2007, ANTIMICROB AGENTS CH, V51, P864, DOI 10.1128/AAC.00994-06
  22. Wirtz VJ, 2010, REV PANAM SALUD PUBL, V27, P219, DOI 10.1590/S1020-49892010000300009
  23. World Health Organization, 2018, WHO REP SURV ANT CON
  24. Zarb P, 2011, J ANTIMICROB CHEMOTH, V66, P443, DOI 10.1093/jac/dkq430